On March 10, 2025, the Maryland Legislature introduced Senate Bill 60, a significant piece of legislation aimed at enhancing preventive healthcare measures for individuals at risk of coronary artery disease. The bill mandates that health insurance entities operating within the state provide coverage for calcium score testing, a diagnostic tool that assesses the presence of coronary artery disease, for individuals who exhibit at least three specific risk factors.

The key provisions of Senate Bill 60 outline that coverage must be extended to individuals with diabetes, high blood pressure, high cholesterol, or a family history of premature coronary artery disease. This initiative seeks to address the growing concern over heart disease, which remains a leading cause of mortality in the United States. By facilitating access to calcium score testing, the bill aims to promote early detection and intervention, potentially reducing the long-term healthcare costs associated with advanced cardiovascular conditions.

The introduction of this bill has sparked notable discussions among lawmakers and healthcare advocates. Proponents argue that the legislation is a crucial step toward improving public health outcomes, particularly for populations disproportionately affected by heart disease. They emphasize that early detection through calcium scoring can lead to timely lifestyle changes and medical interventions, ultimately saving lives.

However, the bill has also faced some opposition. Critics express concerns about the financial implications for insurance providers and the potential for increased premiums. They argue that mandating coverage for specific tests could lead to higher costs for consumers, particularly if the testing is not deemed necessary for all individuals with the identified risk factors. As the bill progresses through the legislative process, these debates are likely to intensify, with stakeholders advocating for a balance between comprehensive care and economic feasibility.

Senate Bill 60 is set to take effect on January 1, 2026, applying to all health policies, contracts, and benefit plans issued or renewed in Maryland. The implications of this legislation extend beyond immediate healthcare access; it reflects a broader commitment to preventive health strategies that could reshape how chronic conditions are managed in the state. As Maryland moves forward with this initiative, the outcomes will be closely monitored, particularly regarding its impact on healthcare costs and patient health outcomes.